Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis.
about
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosisGolgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport VesiclesThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingOn the biomarkers and mechanisms of konzo, a distinct upper motor neuron disease associated with food (cassava) cyanogenic exposure.Altered nucleocytoplasmic proteome and transcriptome distributions in an in vitro model of amyotrophic lateral sclerosisDeregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model.Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).Proteomic assessment of a cell model of spinal muscular atrophyMechanisms of Nrf2 protection in astrocytes as identified by quantitative proteomics and siRNA screeningAlterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeysMitochondrial peroxiredoxin III is a potential target for cancer therapyThe nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset.Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration.Alteration of Golgi Structure by Stress: A Link to Neurodegeneration?Autoimmune Profiling Reveals Peroxiredoxin 6 as a Candidate Traumatic Brain Injury BiomarkerComparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases.Biomarkers for amyotrophic lateral sclerosis.A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutationsStathmin 1/2-triggered microtubule loss mediates Golgi fragmentation in mutant SOD1 motor neurons.Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal modelsExpression and distribution of peroxiredoxins in the retina and optic nerve.Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities.Identification of proteins in human substantia nigra.Morphological changes and altered expression of antioxidant proteins in a heterozygous dynein mutant; a mouse model of spinal muscular atrophy.Age-related changes in HSP25 expression in basal ganglia and cortex of F344/BN rats.Proteomics analysis of BHK-21 cells infected with a fixed strain of rabies virus.Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease.Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1.The heat shock response in neurons and astroglia and its role in neurodegenerative diseases.Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders.Involvement of stathmin 1 in the neurotrophic effects of PACAP in PC12 cells.Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis.Proteome analysis of brain in murine experimental autoimmune encephalomyelitis.Proteome changes associated with hippocampal MRI abnormalities in the lithium pilocarpine-induced model of convulsive status epilepticus.Proteomic identification of peroxiredoxin 6 for host defence against Opisthorchis viverrini infection.Cerebrospinal fluid from amyotrophic lateral sclerosis patients causes fragmentation of the Golgi apparatus in the neonatal rat spinal cord.
P2860
Q24678722-FEAAA015-95BB-4986-A121-B92606BFED89Q26773168-D343ED7A-50D9-4426-897A-7D6FE2695DB3Q28389739-2357A145-4944-4F57-80DF-EAD159E5B9AFQ33600711-C44A8492-243C-442E-99E0-85DFD39AC0D3Q33615051-B8F98C90-8E98-45C7-BE8B-33D1E83DF8F8Q33659976-3D90F0D1-9A2C-4944-A2F4-5F55ED99764AQ33749062-D7B26B94-9E28-48E3-BDB0-03D37DC0850FQ33840295-C3876ECA-EEFE-4B0A-AD4C-439ECD8E9703Q34906371-EF9AA795-8E0C-4A04-97F1-5F07FA1FC69AQ34990005-925C0E20-CF8B-4844-BB63-C524FD9965EBQ35536098-AAFCC11D-AD2A-490D-AD65-119B03F7C1F3Q35946550-681B7F0A-EAFE-490A-A615-22ED004FCFBFQ36190765-885400B8-6A4C-416F-B512-83D93FF112DEQ36271856-A7682D9A-BBF5-44A4-8C89-E888FF2CF6CFQ36294820-15458294-B194-4A16-8137-02FD781BAF98Q36329972-D12D41FA-F6D3-4E3E-86AF-D1E8D7B25EDAQ36481118-EE8128E1-F2DF-4CA7-B06E-A9AA747A4F9FQ36683098-B2BEC452-7BA5-4FE8-A987-F9EE57F492CDQ36986580-6B2B22E1-25F6-4DDB-8176-9242DD9802F9Q37248957-7C9BE4E8-12EF-48B4-AC65-549463226205Q37342352-39AE77C2-6628-4658-9A13-1DDB5492E31FQ37797498-6C3DCF82-9956-4FFC-9156-711E20CA917BQ38513883-FB0C3652-92CA-4E5C-A215-274611C78539Q39386582-641DFA19-E256-4738-B72F-CE4D0304832AQ39829482-2655103C-11B7-4405-AF5A-663FC28784A7Q39868054-08C7428F-2080-46D1-B966-BCBCA2C9090DQ40016546-2E09FF69-25E6-4513-88B8-F5A44F978C55Q40254780-EA6B8989-E6A3-4E8F-A977-1A1D6643746BQ41716408-C190D05E-B713-4053-B80C-AE1ADDA12AFDQ42489979-E184924F-2A8C-4CB4-A0C0-B955EC740D62Q43009480-95CBCE5A-093F-4F09-A833-7C72143FFF30Q46977479-8B6AA2FB-F86A-48E2-8212-36700DA10DD2Q48169554-4D49DBA7-DBEE-4FA7-9074-BE4A1705AE23Q48238067-9A6AD218-F59B-4EEE-96E8-03296B48EAF8Q51773504-AF6EAB71-B260-4AB0-8A99-6B407DECAAE9Q51904521-ADC31159-1858-406B-A330-24B5973408A6
P2860
Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Dysregulation of stathmin, a m ...... amyotrophic lateral sclerosis.
@ast
Dysregulation of stathmin, a m ...... amyotrophic lateral sclerosis.
@en
type
label
Dysregulation of stathmin, a m ...... amyotrophic lateral sclerosis.
@ast
Dysregulation of stathmin, a m ...... amyotrophic lateral sclerosis.
@en
prefLabel
Dysregulation of stathmin, a m ...... amyotrophic lateral sclerosis.
@ast
Dysregulation of stathmin, a m ...... amyotrophic lateral sclerosis.
@en
P2093
P2860
P1476
Dysregulation of stathmin, a m ...... amyotrophic lateral sclerosis.
@en
P2093
Anna Stieber
Christoph W Strey
Daniel Spellman
Jacqueline O Gonatas
John D Lambris
Nicholas K Gonatas
Xiaosong Wang
P2860
P304
P356
10.1016/S0002-9440(10)63426-8
P407
P577
2004-11-01T00:00:00Z